Supplementary Tables and Supplementary Figures 1 through 11 from Secondary Somatic Mutations Restoring &lt;i&gt;RAD51C&lt;/i&gt; and &lt;i&gt;RAD51D&lt;/i&gt; Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma